Items where Funder is AVENTIS PHARMA LIMITED.

The University of Sheffield

Gansevoort, R.T., Hariri, A., Minini, P. et al. (11 more authors) (2023) Venglustat, a novel glucosylceramide synthase inhibitor, in patients at risk of rapidly progressing ADPKD: primary results of a double-blind, placebo-controlled, phase 2/3 randomized clinical trial. American Journal of Kidney Diseases, 81 (5). 517-527.e1. ISSN 0272-6386

Perrone, R.D., Hariri, A., Minini, P. et al. (10 more authors) (2022) The STAGED-PKD 2-stage adaptive study with a patient enrichment strategy and treatment effect modeling for improved study design efficiency in patients with ADPKD. Kidney Medicine, 4 (10). 100538. ISSN 2590-0595

Harrity, J.P.A., Lakeland, C.P. and Watson, D.W. (2020) Exploiting synergistic catalysis for an ambient temperature photocycloaddition to pyrazoles. Chemistry – A European Journal, 26 (1). pp. 155-159. ISSN 0947-6539